Frontlight ResearchEarly access
Head and neck cancer trials in China
216 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleDevelopment and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 170
- Run by
- West China Hospital
See details and how to joinNCT07467083 - Phase 2Taking peopleTraditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients
- Where
- Chengdu
- Age
- 18 years to 65 years
- People
- 118
- Run by
- West China Hospital
See details and how to joinNCT07282483 - Phase 2/3Taking peopleTopical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 60
- Run by
- West China Hospital
See details and how to joinNCT07353671 - Phase 1Taking peopleGV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study
- Where
- Chengdu
- Age
- 18 years to 70 years
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07457281 - Phase 2Not yet taking people in ChinaNano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 52
- Run by
- Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07491783 - Phase 3Taking peopleComparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
- Where
- Changsha, Guangzhou, Guilin, Nanjing, Sanya
- Age
- 18 years to 70 years
- People
- 386
- Run by
- Sun Yat-sen University
See details and how to joinNCT07125755 - Phase 1/2Taking peopleDCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors
- Where
- Chengdu
- Age
- 18 years and over
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07035249 - No phaseNot yet taking people in ChinaImpact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 85
- Run by
- Zhujiang Hospital
See details and how to joinNCT07457099 - Phase 2Taking peopleA Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 76
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07457346 - Phase 2Taking peopleA Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Jinan, Shanghai
- Age
- 18 years to 75 years
- People
- 167
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06857279 - Phase 2Taking peopleA Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
- Where
- Tianjin
- Age
- 18 years to 80 years
- People
- 268
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06208826 - Phase 2Taking peopleIparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 27
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07447570 - No phaseTaking peoplePostoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
- Where
- Bengbu, Changchun, Changsha, Chaoyang, Chengdu, Dalian, Fuzhou, Guandong, Hangzhou, Harbin, Huzhou, Nanchang, Ningbo, Qingdao, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Xi’an
- Age
- 18 years to 70 years
- People
- 190
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07402525 - Phase 3Not yet taking people in ChinaSurgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 184
- Run by
- Sun Yat-sen University
See details and how to joinNCT07402538 - Phase 1/2Taking peopleStudy of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Where
- Baoding, Beijing, Bengbu, Cangzhou, Ch’ang-ch’un, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Dalian, Fuzhou, Ganzhou, Guangzhou, Ha’erbin, Hangzhou, Hanzhong, Harbin, Hefei, Henan, Hohhot, Jiangxi, Jilin City, Jinan, Kunming, Lanzhou, Nanchang, Nanjing, Nanning, Nantong, Qingdao, Qinhuangdao, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taiyuan, Taizhou, Tianjin, Tonghua, Weifang, Wenzhou, Wuhan, Wuhu, Xiamen, Xi’an, Xuzhou, Yantai, Yibin, Yinchuan, Zhengzhou, Zhenzhou
- Age
- 18 years and over
- People
- 400
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT04930432 - Phase 2Not yet taking people in ChinaNeoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT07393477 - Phase 1Taking peopleA Study of SH009 Injection in Patients With Advanced Solid Tumors.
- Where
- Shanghai
- Age
- 18 years and over
- People
- 150
- Run by
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
See details and how to joinNCT07390838 - Phase 2Not yet taking people in ChinaA Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 37
- Run by
- chen chao Professor
See details and how to joinNCT07379424 - Phase 3Taking peopleSintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 104
- Run by
- Qunxing Li,MD
See details and how to joinNCT07371611 - No phaseTaking peopleComparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Qunxing Li,MD
See details and how to joinNCT07369882 - Phase 1Taking peopleFirst in Human Study of SIM0610 in Solid Tumors
- Where
- Chongqing, Harbin, Jinan, Shanghai, Shenyang
- Age
- 18 years and over
- People
- 260
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07348211 - Phase 2Not yet taking people in ChinaA Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT07354984 - Phase 2Taking peopleNimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
- Where
- Shanxi
- Age
- 18 years to 80 years
- People
- 10
- Run by
- Tang-Du Hospital
See details and how to joinNCT07353723 - Phase 2Taking peopleClinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 81
- Run by
- Shanghai Institute Of Biological Products
See details and how to joinNCT06194656 - Phase 3Taking peopleCompare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Shandong
- Age
- 18 years and over
- People
- 335
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT07333274